US Stocks Slide as DeepSeek Sparks Widespread AI SellOff JPMorgans Summer Reading List for Wealthy Clients Highlights AI Leadership and Business Lessons from Lemons Wall Street Ends Mixed as Oil Slides on Iran Deal Hopes Micron Gains 56 GlobalFoundries Drops 9 GLOBALFOUNDRIES Inc Launches Quantum Technology Solutions A New Frontier in Semiconductor Manufacturing Jobless Claims Drop to Lowest Point Since MidMay Signaling Labor Market Resilience Indonesian Commodity Exporters Raise Concerns Over State Monopoly Push Limoneira LMNR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Growing Season KFS Q1 2026 Earnings Loss Per Share of 010 Reported Stock Down Slightly Disc Medicine Q1 2026 Earnings Narrowed Loss Beats Estimates as Biotech Advances Hematology Pipeline ZENA Q4 2025 Earnings Deep Loss Misses Estimates Yet Shares Rally on Strategic Updates KTCC Q1 2026 Earnings Loss Per Share of 026 Reflects Ongoing Pressures ORGO Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Challenges Atlas Lithium ATLX Slides 119 as Selling Pressure Persists Key Support at 394 in Focus Nuburu Inc BURU Reaches 019 as Small Gains Test Key Resistance Terra Property Trust Notes TPTA Hold Steady at 2285 as Support and Resistance Levels Define Range Cardlytics CDLX Slides as Trading Remains Volatile Near Key Support Levels Bonk Inc BNKK Slides 556 as Bearish Pressure Intensifies Near Key Support SpaceX IPO High Valuation Raises Questions Amid Hype and Achievement BOBS Q1 2026 Earnings EPS Surges Past Estimates Stock Rallies PLAYSTUDIOS Inc MYPS Surges 989 as Price Approaches Key Resistance at 051 Harte Hanks HHS Q2 2025 Earnings Narrow Loss Reported as Stock Inches Higher GDS Holdings Q1 2026 Earnings Stunning EPS Beat of 132 vs Expected Loss Chesapeake Utilities Corporation Q1 2026 Earnings Earnings Beat Expectations Stock Slips Slightly NextNRG Inc Q1 2026 Earnings Narrowing Losses Exceed Expectations Amid Strategic Progress MCHP Q1 2026 Earnings EPS Beats Estimates by 106 Stock Rises 255 SCNI Q4 2023 Earnings NarrowerThanExpected Loss Fails to Boost Stock as Revenue Remains Absent Monte Rosa Therapeutics Inc GLUE Q1 2026 Earnings WiderthanExpected Loss Compounds Investor Caution